Lexaria Bioscience Corp. (CSE:LXX; OTCQB:LXRP) is a research-driven company that has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.
Lexaria’s DehydraTECH™ technology is covered by issued and pending patents in over 40 countries around the world. Lexaria’s first patent was issued by USPTO in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034.
Collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. Each of cannabinoids (such as CBD and THC); vitamins; NSAIDs and nicotine are being studied.
First applications for the technology are being used in the legal cannabinoid consumer products space, which is expected to show Compounded Annual Growth Rate (CAGR) of more than 25% through 2021 in North America.
Growth estimates for the legal cannabis industry put it in an elite group of industries that achieved $5 billion in annual revenue and then grew at a > 25% CAGR for the next 5 years.
Lexaria Bioscience trades on the Canadian Securities exchange under the symbol LXX and on the OTCQB under the symbol LXRP.
Lexaria’sCUSIP number is 52886N.
Lexaria’s fiscal year end is August 31.
The next annual general meeting will be announced when available.
MNP LLP act as Lexaria’s external auditors.
Lexaria’s transfer agent is Computershare Investor Services Inc.
Phone: (800) 564-6253
Shareholder and Investor Relations Contact
Manager Corporate Communications and Investor Relations
|Shares issued and outstanding||66,972,303|
|Insider ownership – fully diluted||16,985,549|
|September 1-2, 2017||Investorshub International Cannabis Conference||Los Angeles|
|September 7-8, 2017||IC3||Miami|
|September 30, 2017||NAI Conference||Toronto|
|October 12-14, 2017||SWCC Phoenix||Phoenix|
|October 14, 2017||NAI Conference||Vancouver|
|November 14-17, 2017||Marijuana Business Conference and Expo||Las Vegas|
|December 5-7, 2017||LD Micro||Los Angeles|
|February 1-2, 2018||International Cannabis Business Conference||San Francisco|
|April 12-13, 2018||International Cannabis Business Conference||Berlin|
LXRP: OTCQB – http://www.otcmarkets.com/stock/LXRP/quote
Davidson & Company LLP
1200 – 609 Granville St
PO Box 10372, Pacific Centre
Suite 400, 570 Granville Street
Vancouver BC Canada
Intellectual Property Lawyers:
6000 Fairview Road
Charlotte, NC 28210
Fenno Law Firm, LLC
171 Church Street
Charleston, SC 29401